C1q Potentiates Dr5 Agonist Activity By A Mixture Of Two Dr5-Specific Hexabody Molecules

MOLECULAR IMMUNOLOGY(2018)

引用 0|浏览33
暂无评分
关键词
C1q, Immunotherapy, Crosslinking, Cancer, DR5, Hexamerization
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要